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ABSTRACT
BACKGROUND AND PURPOSE: Diffusional kurtosis imaging is an MR imaging technique that provides microstructural information in
biologic systems. Its application in clinical studies, however, is hampered by long acquisition and postprocessing times. We evaluated a new
and fast (2 minutes 46 seconds) diffusional kurtosis imaging method with regard to glioma grading, compared it with conventional
diffusional kurtosis imaging, and compared the diagnostic accuracy of fast mean kurtosis (MK) to that of the widely used mean diffusivity.
MATERIALS AND METHODS: MK and mean diffusivity were measured in the contrast-enhancing tumor core, the perifocal hyperinten-
sity (indicated on T2 FLAIR images), and the contralateral normal-appearing white and gray matter of 34 patients (22 with high-grade and
12 with low-grade gliomas). MK and mean diffusivity in the different tumor grades were compared by using a Wilcoxon rank sum test.
Receiver operating characteristic curves and the areas under the curve were calculated to determine the diagnostic accuracy of MK and
mean diffusivity.
RESULTS: MK in the tumor core, but not mean diffusivity, differentiated high-grade from low-grade gliomas, and MK differentiated
glioblastomas from the remaining gliomas with high accuracy (area under the curveMK  0.842; PMK  .001). MK and mean diffusivity
identified glioblastomas in the group of high-grade gliomas with similar significance and accuracy (area under the curveMK  0.886; area
under the curvemean diffusivity  0.876; PMK  .003; Pmean diffusivity  .004). The mean MK in all tissue types was comparable to that obtained
by conventional diffusional kurtosis imaging.
CONCLUSIONS: The diffusional kurtosis imaging approach used here is considerably faster than conventional diffusional kurtosis imaging
methods but yields comparable results. It can be accommodated in clinical protocols and enables exploration of the role of MK as a
biomarker in determining glioma subtypes or response evaluation.
ABBREVIATIONS: AC  astrocytoma; DKI  diffusional kurtosis imaging; GBM  glioblastoma multiforme; HGG  high-grade glioma; LGG  low-grade glioma;
MD  mean diffusivity; MK  mean kurtosis; MK  fast mean kurtosis; NAGM  normal-appearing gray matter; NAWM  normal-appearing white matter
Diffusion-weighted and diffusion tensor imaging are currentlyused in patients with cerebral glioma as presurgical imaging
tools for the World Health Organization grading system, neuro-
navigation, and response evaluation during radiochemotherapy
or antiangiogenic treatment.1 DTI and DWI approximate the dis-
placements of diffusing water molecules by a Gaussian distribution as
if water molecules were moving unrestricted in all directions. How-
ever, it is well established that the diffusion signal from cerebral water
molecules for moderate-to-high values of the magnetic gradient field
is not described accurately by the standard monoexponential decay
as a function of the diffusion weighting (b-value).2
Diffusional kurtosis imaging (DKI) is a recently described MR
imaging technique that aims to provide additional microstruc-
tural information by extending the DTI model to incorporate
fourth-order gradient field terms in the diffusion signal.2 In this
higher-order description of diffusion signal decay, the dimen-
sionless kurtosis term describes the degree of deviation from the
Gaussian distribution of spin displacements along the axis of ob-
servation. When averaged over all directions, the mean kurtosis
(MK) is obtained.2 The deviation from free (Gaussian) diffusion
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is generally assumed to be caused by tissue microstructure, and
MK is therefore interpreted as a general microstructural marker.3
Use of the DKI model may be beneficial in 2 ways: 1) the diffusion
tensor is indirectly corrected through the higher-order terms,4
and 2) the additional microscopic diffusion characteristics
may be used for clinical purposes. Compared with gray matter
or edematous tissue, white matter and malignant tumors are
characterized by higher architectural complexity that results
from cell membranes, organelles, axons, or vascular structures
impeding proton diffusion and leading to higher non-Gaussi-
anity and increased MK.5
Gliomas are a heterogeneous group, categorized as low-grade
glioma (LGG) and a high-grade glioma (HGG) with different his-
topathologic features, such as cellularity or the presence or ab-
sence of necrosis and neoangiogenesis. This heterogeneity is likely
to be reflected in MK alterations, and promising first studies have
reported MK as an imaging-based means of presurgical glioma
grading.6,7 Larger studies and the more widespread use of DKI,
however, have been held back by relatively long acquisition times
that result from a model requirement for data to be obtained
along several directions at each of many b-values.8 Such protocols
are clearly incompatible with the daily routines in busy clinical
imaging departments and are often not tolerable by critically ill
patients.
We recently proposed a kurtosis method9,10 that is much faster
than traditional kurtosis-acquisition schemes,2,4 in terms of both
acquisition and postprocessing times, and on the basis of this
method we present here our first clinical results in 34 patients with
glioma. We correlated MK values with histopathologic grades and
compared them with those from the literature. Moreover, we
compared the diagnostic accuracy of MK with that of the widely




Thirty-five patients with cerebral gliomas were included in this
retrospective study. A waiver from the local ethics committee
was granted, because DKI was acquired without increasing the
scan time by modification of the diffusion-weighted sequence
that is a part of our routine clinical protocol. Apart from ste-
roids in some patients with glioblastoma multiforme (GBM),
these patients did not receive any treatment at the time of
imaging. One patient had to be excluded because of motion
artifacts on conventional sequences so severe that reliable tu-
mor outlining could not be performed. The diagnosis of gli-
oma (22 HGGs, 12 LGGs) was determined by biopsy or resec-
tion in 30 cases. Three of the remaining 4 cases without
histopathology results were considered to be LGG and 1 was
considered to be GBM; these diagnoses were based on the clin-
ical behavior and imaging characteristics on conventional MR
imaging. Two of 34 patients, both with LGG, had undergone
surgery many years before being included in this study and
were re-imaged because of disease recurrence. Included were
15 patients with GBM, 5 with a grade III astrocytoma (AC), 2
with a grade III oligodendroglioma, and 12 with an LGG (3
with a proven grade II oligodendroglioma). One tumor was
classified as a grade II oligodendroglioma with a minor astro-
cytic component and was subsequently included in the group
of those with a grade II oligodendroglioma.
Imaging
MR imaging was performed on a Skyra 3T system (Siemens, Er-
langen, Germany) with a standard 20-element head coil. The MR
imaging protocol consisted of 3D T1-weighted images before and
after intravenous contrast (0.1 mmol/kg gadoterate meglumine;
TR, 2300 ms; TE, 3.8 ms; voxel size, 1  1  1 mm3; FOV, 256 
256 mm2; acquisition time, 349 s) and axial precontrast T2 FLAIR
images (TR, 9000 ms; TE, 117 ms; TI, 2500 ms; voxel size, 0.7 
0.7  3 mm3; FOV, 230  220 mm2; acquisition time, 326 s).
Axial DKI was performed before intravenous contrast (TR, 10,300
ms; TE, 100 ms; voxel size, 2  2  2 mm3; FOV, 196  196 mm2;
number of excitations, 1; sections, 60; acquisitions, 3 [one along
each of the x-, y-, and z-directions] with b1000 s/mm2, 9
different directions [as specified in Hansen et al9] with b2500
s/mm2, and 1 acquisition with b0 s/mm2; 13 diffusion-
weighted images in total). The acquisition time for DKI was
166 seconds.
MR Imaging Data Analysis
In the framework of the fast kurtosis sequence,9 W , the mean of
the kurtosis tensor W, is computed, and it was shown to be very
similar numerically to the traditional MK. Here, we refer to it as
MK for convenience. MK is calculated from 13 diffusion-
weighted images: 1 b0 scan for normalization, 3 images at
b1000 s/mm2 along each of the x-, y-, and z-directions, and 9
images at b2500 s/mm2 along the 9 directions defined in Hansen
et al.9 From these data, a robust estimate of MD can also be
achieved with the kurtosis term taken into account in its calcula-
tion, which was shown to improve MD estimates4 and imple-
mented as proposed in Jensen et al.11
Postprocessing of the DKI data, including the reslicing and
co-registration steps, were performed by running modules de-
veloped in-house in SPM8 (http://www.fil.ion.ucl.ac.uk/spm/
software/spm8) and Matlab (MathWorks, Natick, Massachusetts).
Contrast-enhanced T1-weighted images were resliced to T2
FLAIR. A neuroradiologist, blinded for the histopathologic diag-
nosis (A.T., 5 years of experience), outlined the tumor core (con-
trast-enhancing part), the perifocal hyperintensity on T2 FLAIR
(hereafter termed FLAIR mask), and regions of normal-appearing
white and gray matter (NAWM and NAGM, respectively) in the
contralateral centrum semiovale and thalamus (Fig 1). In cases of
a nonenhancing lesion, only T2 FLAIR was used to define the
tumor. Normal vessel structures, necrotic areas, and potential
blood products were avoided, guided by conventional se-
quences. Tumor core, FLAIR masks, contralateral NAWM
masks, contrast-enhanced T1, and T2 FLAIR images were sub-
sequently co-registered and resliced to the localization of the
DKI data. The co-registration step was checked visually by
using SPM8.
The duration of the DKI sequence is quite short (166 seconds);
hence, it was deemed unnecessary to perform motion correction
of the individual volumes. The validity of this strategy was verified
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in all cases by visual inspection of all diffusion images. To remove
possible spurious voxels, the DKI data were up-sampled by a fac-
tor of 2 in all directions by using linear interpolation and subse-
quently smoothed by a 2  2  2–mm3 kernel. The spatial dis-
tortions introduced in the images by eddy currents were
compensated to some extent by using a double spin-echo se-
quence, which is currently the best clinically viable solution (it
does not add additional time to the scan sequence). The postpro-
cessing of a single DKI dataset took 3–5 seconds.
Statistical Analysis
Statistical analysis was performed by using R Studio (http://rstudio.
org/download/desktop) and Matlab. Voxelwise values of MD
and MK values were extracted from the 4 regions. The MK and
MD values were normalized by calculating the ratio of tumor core
values and the individual mean values obtained in the contralat-
eral NAWM (termed nMK and nMD, respectively). The same
was done for values in the FLAIR masks. The mean values in all the
regions were computed. To evaluate data variations of MK and
MD, we calculated the coefficient of variation in pathologic tissue
in contralateral normal-appearing tissue (NAWM and NAGM).
A paired t test was performed to assess whether variations of MK
and MD were significantly different. A Wilcoxon rank sum test
was used to compare mean MK and MD values between tumor
types and grades. The statistical threshold for significant discrim-
ination was set to a P value of  .05. Receiver operating charac-
teristic curves were constructed to determine the diagnostic per-
formance of MK, MD, nMK, and nMD. The area under the
receiver operating characteristic curve was used to measure the
accuracy, and P values were used to measure strength. Moreover,
logistic regression was performed to investigate whether the com-
bination of MK and MD increased the area under the curve and
thereby the diagnostic performance. Finally, the sensitivity and
specificity for discriminating HGG, LGG, and specific tumor
grades were determined.
RESULTS
Typical examples of an LGG (grade II AC, upper panel A) and an
HGG (GBM, lower panel B) are shown in Fig 2. Note the areas
with increased MK and decreased MD in the GBM, whereas MK
is low and MD is high in the grade II AC case.
Nonnormalized and normalized mean values of MK and MD
in the contrast-enhancing tumor core (or the hyperintense area
on T2 FLAIR, for nonenhancing tumors) for the different tumor
types and grades are shown in Fig 3. Median values for tumor
types and grades along with measurements in the contralateral
NAWM and NAGM are given in the On-line Table. The data
variation in NAWM was significantly larger (P  .001) for MD
(coefficient of variation  0.122  0.019) than for MK (coeffi-
cient of variation  0.093  0.013), and MD values varied slightly
less (coefficient of variation  0.163  0.058) than the MK values
(coefficient of variation  0.189  0.043) in NAGM (P  .036).
The mean value of MK in the tumor core was significantly
higher in HGGs than in LGGs. nMK was increased in HGGs, but
it was with a P value of .058, which is above the threshold for
statistical significance. MD and nMD were not significantly dif-
ferent between the HGGs and LGGs. MK and nMK were in-
creased, and MD and nMD were decreased in GBMs when com-
paring them with the remaining HGGs or with the entire study
group consisting of HGGs and LGGs (all P  .05). In the group of
HGGs, grade III AC cases were identified by MK, MD, nMK,
and nMD. It was not possible to discriminate groups by values in
the FLAIR masks. All P values are reported in Table 1.
The receiver operating characteristic curves for the discrimi-
nation between HGGs and LGGs showed higher areas under the
curve for MK and nMK than for MD and nMD in the tumor
core. The areas under the curve for the differentiation between
FIG 1. The tumor core was defined as the contrast-enhancing part on
postcontrast T1-weighted images, and the FLAIR masks were defined
as hyperintense regions on T2 FLAIR images (minus the tumor core
and necrosis, if present). In cases of nonenhancing tumors, hyperin-
tensity areas on T2 FLAIR images were defined as the tumor core (the
tumor core and edema were identical regions). The NAWM was out-
lined in the centrum semiovale of the contralateral hemisphere (on
4 consecutive sections). The NAGM was defined in the contralateral
thalamus (on 3 sections).
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GBMs and the remaining gliomas were higher for MK and nMK
than for the corresponding MD values. When identifying grade III
AC cases, MK and MD performed similarly. Areas under the
curve calculated from values in the FLAIR masks were either low
or not statistically significant. Combining MK and MD or nMK
and nMD could increase accuracy, but only MK and nMK con-
tributed to the logistic regression model differentiating HGGs
from LGGs or identifying GBMs in the entire glioma group. Area
under the curve values are given in Table 2. GBMs were diagnosed
with 87% sensitivity and 74% specificity with a cutoff MK value
of 0.58 (87% sensitivity and 74% specificity for an nMK value of
FIG 2. A, Contrast-enhanced T1-weighted and T2 FLAIR images of a grade II astrocytoma grade in the left hemisphere. The map of MK
demonstrates low MK, whereas the trace image and the MD map show high diffusivity (high signal changes on MD). B, Typical example of a
glioblastoma, with contrast enhancement on postcontrast T1-weighted and complex signal changes on T2 FLAIR images. Increased MK is noted
in most of the tumor. The trace image and MD show restricted diffusion, primarily in the periphery of the lesion.
FIG 3. Boxplots of average MK and normalized MK (in yellow) (A) and MD and normalized MD (in blue) (B) in the contrast-enhancing
tumor core of all patients, grouped according to tumor types and grades, are shown. The horizontal lines in the boxes are the median
values, the upper and lower box edges are the 25th and 75th percentiles, respectively, and the upper and lower whiskers represent the
minimums and maximums, respectively. AC indicates grade III astrocytoma; ODG3, grade III oligodendroglioma; AC2, grade II astrocy-
toma; ODG2, grade II oligodendroglioma.
Table 1: Significance of mean MK, nMK, MD, and nMD values in
different tumor gradesa
Tumor Type MK= nMK= MD nMD
HGG/LGG .028b .058 .383 .511
GBM/all .001b .002b .006b .006b
GBM/HGG .003b .011b .004b .004b
AC3/all .135 .135 .063 .033b
AC3/HGG .011b .031b .024b .019b
Note:—AC3 indicates grade III astrocytoma.
a Mean MK, nMK, MD, and nMD values in the tumor core were compared between
different tumor grades, and the resulting P values are listed.
b A P value of .05 indicates a significant difference between groups.
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0.60), whereas the corresponding sensitivity and specificity for an
MD value of 1.460 were 80% and 63%, respectively (80% sensi-
tivity and 63% specificity for an nMD value of 1.683).
DISCUSSION
In this study, we investigated MK in the tumor core and the
perifocal hyperintensity on T2 FLAIR images in different glioma
grades. Our data were acquired with a new and rapid DKI
method9 that is easily implemented and provides fast acquisition
and postprocessing times, which make it potentially useful in clin-
ical departments and for larger studies. The discrimination be-
tween HGGs and LGGs was possible only by means of MK, and
the MK and MD values allowed us to identify cases of GBM in the
HGG group and in the entire study population. Our receiver op-
erating characteristic analyses revealed high accuracy for MK and
nMK, represented by high areas under the curve. Although we
chose to correct MD for the non-Gaussian phenomena (described
in “Materials and Methods”) to obtain more accurate measure-
ments, we found that MK was still superior to MD in diagnosing
GBMs when evaluating a group of mixed glioma types, whereas
MD and MK perform similarly when analyzing only HGGs.
Moreover, we showed that MK data variation was significantly
smaller in NAWM and larger in NAGM. The high b-values, used
for DKI, dampen the signal considerably, and with noise being
constant, the signal-to-noise ratio decreases. Because MD is
higher in NAGM than in NAWM, the decrease in signal-to-noise
ratio is expected to be more distinct in NAGM, negatively impact-
ing parameter estimates and causing larger variation.
Currently, few studies in which DKI parameters in patients
with glioma were investigated have been published. Van Cauter et
al7 examined 28 patients (17 with an HGG and 11 with an LGG,
both oligodendroglial and astrocytic types) with a conventional
DKI sequence taking 17 minutes 29 seconds and showed a signif-
icant difference in MK, nMK, and nMD values between HGGs
and LGGs, with areas under the curve of 0.8 for all 3 values.
Median values in the tumor core, the perifocal hyperintensity on
T2 FLAIR images, and the contralateral NAGM were similar to
ours, but the median value for the contralateral NAWM was con-
siderably lower than ours.7 The higher MK values for NAWM
measured in our study corresponds better, however, to values
reported earlier.2,9 Values for single tumor grades (eg, GBM or
grade III AC) were not reported by these studies. Raab et al6 eval-
uated 33 patients with an astrocytoma only (AC grade 2, AC grade
3, or GBM) by using a DKI sequence that took 11 minutes 57
seconds. Mean MK values in the core of grade II ACs, grade III
ACs, and GBMs were somewhat higher in their study (between
0.09 higher for nMK in grade III ACs and 0.14 for MK in GBMs),
and their ability to separate tumor grades was slightly better than
ours. Several possible causes for these discrepancies are conceiv-
able, including unconfirmed histopathology in 4 of our cases,
previous surgery,3 the risk of misdiagnosis caused by imprecise
sampling in cases of biopsy, the inclusion of gliomas with both
oligodendroglial and astrocytic histology results, differences be-
tween the MR imaging systems used for data acquisition (partic-
ularly gradient performance and its influence on diffusion times
and achievable echo times), different technical and postprocess-
ing approaches, and the distinct physical nature of MK and MK.
We were able to differentiate HGGs from LGGs by means of
MK, but our separation of GBMs and AC3s from the remaining
gliomas might be clinically even more critical than the rough clas-
sification of HGGs and LGGs that in most cases is accomplished
by conventional or perfusion-weighted MR imaging.12 Even
more detailed subtyping of gliomas in those with a relatively fa-
vorable outcome and those with a poor outcome are becoming
increasingly relevant, because different therapeutic approaches
can be considered. The prediction of patient outcome by means of
imaging biomarkers correlating them with genomic subtypes is an
expanding field, and MK should be included in the future.13 We
also suggest that DKI might be an important diagnostic tool for
assessing tumor progression and treatment response. It is well
known that LGGs progress to higher grades with time, a process
that is essential to monitor for accurately timed treatment adjust-
ment, and gradually increasing MK might be a valuable tool for
detecting these subtle changes in dedifferentiation. Therefore, vi-
sualization of aggressive regions within a lesion by detailed MK
mapping could have important implications on the neurosurgical
approach or radiation treatment planning. A promising addi-
tional application area for DKI is response evaluation of patients
during antiangiogenic treatment, which is currently a diagnostic
challenge.14 Our fast DKI protocol with very short postprocessing
times enables real-time image reconstruction on the scanner and
is therefore a promising tool for integrating multimodal evalua-
tion of patients with glioma.
Only a small number of patients were included in this study,
which might limit its power but can also be regarded as a strength,
Table 2: Results of regression analysisa
Tumor Type MK= P nMK= P MD P nMD P MK= + MD Pb nMK= + nMD Pb
HGG/LGG 0.731 .045c 0.701 .056 0.595 .512 0.572 .456 0.754 .032c 0.746 .041c
.220 .213
GBM/all 0.842 .004c 0.811 .004c 0.775 .017c 0.772 .014c 0.842 .045c 0.807 .047c
.796 .835
GBM/HGG 0.886 .027c 0.838 .022c 0.876 .018c 0.876 .019c 0.895 .127 0.905 .181
.204 .184
AC3/all 0.717 .146 0.717 .170 0.766 .052 0.800 .060 0.793 .744 0.779 .885
.165 .155
AC3/HGG 0.871 .039c 0.824 .055 0.835 .038c 0.847 .042c 0.882 .127 0.871 .301
.328 .265
Note:—AC3 indicates grade III astrocytoma.
a The areas under the receiver operating characteristic curves as a measure for diagnostic accuracy are reported.
b Two P values occur when two values (MK and MD) are tested at the same time.
c The variable contributes significantly to the regression model if the corresponding P value is .05.
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because we still showed a significant difference between tumor
grades. We aimed to compare our new method with that of 2
previously published studies in which a data volume of approxi-
mately the same scale was investigated, and we could reproduce
most of their results with a fast sequence that maps MK on the
basis of only 13 images (2 minutes 46 seconds in our case) and a
DKI postprocessing time of just a few seconds. Other metrics that
evaluate directional non-Gaussianity, such as axial or radial kur-
tosis, have been described and may be of interest, because they are
likely to reveal different and supplemental information about mi-
crostructure.15 These kurtosis metrics cannot be estimated from
the data, because they are derived from the full kurtosis tensor,
and reliable estimation of the tensor would require the measure-
ment of additional diffusion directions and the nonlinear fitting
of the results to a diffusion model. These requirements would add
considerably to the scanning and postprocessing times, which
would be particularly inexpedient in clinical applications. As a
result, the significance of these measures for tumor grading was
not evaluated in this study. Axial and radial kurtosis were assessed
by Van Cauter et al,7 but the diagnostic impact of these parame-
ters did not differ considerably from the MK in their study. A
limitation of our study is that some of the patients with GBM
received steroid treatment at the time of imaging. Steroids might
have an influence on MK, MK, and MD values by reducing the
amount of edema. We are not able to correct for this effect. Fi-
nally, potential partial volume effects caused by co-registration
steps might have influenced the results. We inspected our data for
co-registration errors closely and adjusted them thoroughly to
avoid the inclusion of CSF and necrosis, but inexactness was still
possible.
The increasing MK in GBM is interesting with regard to the
underlying microstructural characteristics of these tumors. Little
is known about what might cause MK alterations, but it has been
postulated that changes in the quantity of cell membranes and the
amount of intracellular and extracellular protein are likely to in-
fluence the degree of non-Gaussianity.16 The chaotic vascular ar-
chitecture of and micronecrosis in GBMs might contribute fur-
ther to the microstructural complexity causing an increase in MK.
The association between increased cellularity and restricted water
diffusion, estimated by MD, was investigated in several previous
studies,17-19 but the utility of this parameter was not always re-
confirmed.20,21 A weak correlation can be a result of concomitant
MD increases caused by edema and micronecrosis in HGGs, and
it remains to be shown if MK can add important diagnostic infor-
mation. MK calculated from a conventional DKI sequence and
MK obtained by our fast method are distinct quantities, because
they are estimated in a different way. However, it was shown that
they are highly correlated both in normal brain9 and in acute
stroke tissue.22 We are not able to compare both approaches, be-
cause only the rapid version was acquired, but we expect this
correlation to be the same in our patients and avail ourselves of
the comparison with literature values.
CONCLUSIONS
We have shown that MK is a valuable tool for glioma grading and
that our fast DKI method provides robust measurements compa-
rable to those from the literature. These results enable larger-scale
implementation of DKI in clinical studies and allow for the inves-
tigation of its significance in treatment evaluation, diagnosis of
LGG dedifferentiation, and detection of recurrent disease. More-
over, imaging with a rapid DKI technique in clinically unstable
patients, such as those after a stroke or trauma, has the potential to
provide new insights into the pathophysiology and longitudinal
progression of these diseases.22-25
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